WE
Focus on
the
discovery
Learn More
Founded in
2006
Employee Number
300
Talents with Master's & Doctoral degrees
23%
10
R&D Platform
More than
40
Patents
55
Registered Medical Device Products
2006
300
23%
R&D Platform
40
Patents
Registered Medical Device Products
Founded in 2006, Shanghai Dunwill Medical Technology Development Company is a world's leading research-based IVD company focused on the discovery, development, and commercialization of innovative original biomarker. Based on our insight of systems biology and multi-omics technology, we work with clinical experts on the development mechanism of complex diseases from the "spatial and temporal dimension" and develop original clinical IVD products with own independent intellectual property rights.
Jusbio Sciences and Epione MedLab, two biomedical high-tech enterprises of Dunwill, is a one-stop solution provider of multi-omics R&D platforms, covering genomics, cell phenomics, proteomics, bioinformatics, Al, etc. Our products are IVD test kits and automated instruments and equipment in PCR, CTC, NGS, MS and other platform. One of our products, "miRNA7 Test Kit", is the world's first molecular IVD product for liver cancer, which has been covered in the Shanghai Medical Insurance Catalogue since April 2021 and is included in the "Primary Liver Cancer Treatment Guidelines (2024 Edition)" issued by the National Health Commission.
2006
300
23%
R&D Platform
40
Patents
Registered Medical Device Products
Founded in 2006, Shanghai Dunwill Medical Technology Development Company is a world's leading research-based IVD company focused on the discovery, development, and commercialization of innovative original biomarker. Based on our insight of systems biology and multi-omics technology, we work with clinical experts on the development mechanism of complex diseases from the "spatial and temporal dimension" and develop original clinical IVD products with own independent intellectual property rights.
Jusbio Sciences and Epione MedLab, two biomedical high-tech enterprises of Dunwill, is a one-stop solution provider of multi-omics R&D platforms, covering genomics, cell phenomics, proteomics, bioinformatics, Al, etc. Our products are IVD test kits and automated instruments and equipment in PCR, CTC, NGS, MS and other platform. One of our products, "miRNA7 Test Kit", is the world's first molecular IVD product for liver cancer, which has been covered in the Shanghai Medical Insurance Catalogue since April 2021 and is included in the "Primary Liver Cancer Treatment Guidelines (2024 Edition)" issued by the National Health Commission.
Founded in 2006, JUSBIO SCIENCES (SHANGHAI) CO., LTD is a national “High-Tech Enterprises” providing professional medical diagnostic reagents, instruments, technologies and services for hospitals and laboratories. It has obtained Class III Medical Device Manufacturing License and more than 55 registered products. It has been certified by the National Ministry of Industry and Information Technology as a Specialized, Refined, Innovative and New “Little Giant” Enterprise, Shanghai Science and Technology Small Giant Cultivating Enterprise, Shanghai Specialized, Refined, Innovative and New Small and Medium-sized Enterprises and other honors. JUSBIO has passed ISO13485:2016 international quality system certification, and has been awarded with Shanghai Quality System Class A Certification for 15 years.
By the innovative integration of medical institutions, research facilities and manufacturers, JUSBIO transforms the latest domestic and international scientific research results applicable to the clinics into IVD diagnostic reagents and related instruments and equipment, and serves major medical institutions in China.
Epione Medlab Co. Ltd. was founded in 2017 as a third-party medical laboratory focusing on molecular testing and pathology services, with a total laboratory area of more than 2,800 square meters. 30% of the employees hold a master's degree or above. We have several technology platforms, including pathology analysis, quantitative nucleic acid analysis, circulating tumor cell analysis, high-throughput sequencing, mass spectrometry analysis, 10x single-cell sequencing, spatial multi-omics, and bioinformatics analysis, etc. We could flexibly adapt to different needs and provide one-stop solutions for our customers.
Epione Medlab was accredited by the College of American Pathologists (CAP) in 2021 for the first time and reaccredited with zero deficiencies in 2023.
Established in 2013 in San Diego, Genovo Inc. is engaged in R&D of IVD reagents and instruments of first-in-class biomarkers.
The Company is a global leader in miRNA testing and automatic nucleic acid workstation technology.
Established in 2008, MinSheng Medical Technology Co., Ltd. is a first-tier distributor in China of IVD products of Roche Diagnostics and other internationally renowned medical device products.
Integrated Solution of the Discovery, Development and Commercialization of Original Biomarker
Driven by Clinical Needs
Utilizing Multi-omics Technology
An Innovative Medical Industry Model with Close Cooperation & Collaborative Development across Multiple Platforms Has Been Formed
miRNA7 Test Kit
Included in the "Primary Liver Cancer Treatment Guidelines (2024 Edition)" issued by the National Health Commission
30% Higher Detection Rate of Early-stage Liver Cancer than Traditional Methods such as AFP
Indicates the Risk of Hepatocellular Carcinoma 11.5 months Earlier than Radiography
Nearly 20 Years of National Commercial Operation Experience
Covering Top 100+ Class A Tertiary Hospital
Across 29 Provinces and Cities Nationwide
Dunwill Testing Service Platform
Provide 2 Kinds of Testing Services
Dunwill Scientific Research Platform
Provide 7 Kinds of Scientific Research Services
- Contact Us
-
Join Us
